Literature DB >> 1696315

Decision making in advanced cancer of the head and neck: variation in the views of medical specialists.

E J Maher1, A F Jefferis.   

Abstract

Forty specialists were asked about their management of three theoretical patients with advanced cancer of the head and neck. Reasons for variation were explored by considering the influence of perceived aims of treatment (radical or palliative), together with a number of factors relating to the tumour, the lymph nodes, and the patients' personal circumstances. The perceived aim of treatment was the most important determinant as to treatment modality but, when chances of influencing survival were small, there was disagreement as to the appropriate aim and subjective value judgements became influential. More careful analysis of the initial decision-making process is needed if new clinical trials are to significantly affect clinical practices.

Entities:  

Mesh:

Year:  1990        PMID: 1696315      PMCID: PMC1292683          DOI: 10.1177/014107689008300607

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  5 in total

1.  Cancer of the tongue. Report of the management of 1,554 patients.

Authors:  E L FRAZELL; J C LUCAS
Journal:  Cancer       Date:  1962 Nov-Dec       Impact factor: 6.860

2.  Measuring the quality of life of cancer patients: a concise QL-index for use by physicians.

Authors:  W O Spitzer; A J Dobson; J Hall; E Chesterman; J Levi; R Shepherd; R N Battista; B R Catchlove
Journal:  J Chronic Dis       Date:  1981

3.  Cancer of the pharynx. A study based on 2,417 cases with special reference to radiation treatment.

Authors:  M Lederman
Journal:  J Laryngol Otol       Date:  1967-02       Impact factor: 1.469

4.  Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer.

Authors:  B J McNeil; R Weichselbaum; S G Pauker
Journal:  N Engl J Med       Date:  1981-10-22       Impact factor: 91.245

5.  Who should measure quality of life, the doctor or the patient?

Authors:  M L Slevin; H Plant; D Lynch; J Drinkwater; W M Gregory
Journal:  Br J Cancer       Date:  1988-01       Impact factor: 7.640

  5 in total
  3 in total

1.  Advanced head and neck cancer.

Authors:  A Ordóñez; J I Chacon
Journal:  J R Soc Med       Date:  1991-01       Impact factor: 5.344

2.  Chemotherapy for advanced breast cancer: what influences oncologists' decision-making?

Authors:  E A Grunfeld; A J Ramirez; E J Maher; D Peach; T Young; I P Albery; M A Richards
Journal:  Br J Cancer       Date:  2001-05-04       Impact factor: 7.640

3.  Consensus standards for the process of cancer care: a modified expert panel method applied to head and neck cancer. South and West Expert Tumour Panel for Head and Neck Cancer.

Authors:  M A Birchall
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.